The Consensus Coding Sequences of Human Breast and Colorectal Cancers
Tobias Sjöblom, Siân Jones, Laura DeLong Wood et al. · Science · 2006
The elucidation of the human genome sequence has made it possible to identify genetic alterations in cancers in unprecedented detail. To begin a systematic analysis of such alterations, we determined the sequence of well-annotated human protein-coding genes in two common tumor types. Analysis of 13,023 genes in 11 breast and 11 colorectal cancers revealed that individual tumors accumulate an average of approximately 90 mutant genes but that only a subset of these contribute to the neoplastic process. Using stringent criteria to delineate this subset, we identified 189 genes (average of 11 per tumor) that were mutated at significant frequency. The vast majority of these genes were not known to be genetically altered in tumors and are predicted to affect a wide range of cellular functions, including transcription, adhesion, and invasion. These data define the genetic landscape of two human cancer types, provide new targets for diagnostic and therapeutic intervention, and open fertile avenues for basic research in tumor biology.
Cited by 3,169 works. doi:10.1126/science.1133427
Authors
- Tobias Sjöblom
- Siân Jones
- Laura DeLong Wood
- Donald Williams Parsons
- Jimmy Lin
- Thomas D. Barber
- Diana L. Mandelker
- Rebecca J. Leary
- Janine Ptak
- Natalie Silliman
- Steve Szabo
- Phillip Buckhaults
- Christopher L. Farrell
- Paul F. Meeh
- Sanford D. Markowitz
- Joseph E. Willis
- Dawn M. Dawson
- James K. V. Willson
- Adi F. Gazdar
- James Hartigan
References
- Global Cancer Statistics, 2002
- p53 Mutations in Human Cancers
- Base-Calling of Automated Sequencer Traces Using Phred. II. Error Probabilities
- Prevalence of ras gene mutations in human colorectal cancers
- A census of human cancer genes
- Genetic instabilities in human cancers
- Inactivation of the Type II TGF-β Receptor in Colon Cancer Cells with Microsatellite Instability
- Integrated Genomic and Proteomic Analyses of a Systematically Perturbed Metabolic Network
- Cancer genes and the pathways they control
- GTPase inhibiting mutations activate the α chain of Gs and stimulate adenylyl cyclase in human pituitary tumours